Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
NuVasive has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Surgical Devices Companies in APAC - 2021,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Chris Barry, CEO.
Company
NuVasive
Management
Chris Barry, CEO
Description
A company focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions. NuVasive’s less invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The company’s comprehensive procedural portfolio includes access, implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. To this extent, NuVasive has recently unveiled the single best anterior cervical system on the market with a comprehensive portfolio called C360™. The C360 portfolio integrates with best-in-class access instrumentation, implants, enabling technologies, and biologic materials into a procedural solution
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
